Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-06-01
著者
-
SICCARDI Marco
Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital
-
Watson Victoria
Department Of Pharmacology And Therapeutics University Of Liverpool
-
Hughes Andrew
Nihr Biomedical Research Centre Royal Liverpool Hospital Trust
-
Siccardi Marco
Department Of Pharmacology And Therapeutics University Of Liverpool
-
Siccardi Marco
Department Of Infectious Diseases University Of Torino. Amedeo Di Savoia Hospital
-
ELSE Laura
Department of Pharmacology and Therapeutics, University of Liverpool
-
TJIA John
Department of Pharmacology and Therapeutics, University of Liverpool
-
KHOO Saye
Department of Pharmacology and Therapeutics, University of Liverpool
-
BACK David
Department of Pharmacology and Therapeutics, University of Liverpool
-
Else Laura
Department Of Pharmacology And Therapeutics University Of Liverpool
-
Tjia John
Department Of Pharmacology And Therapeutics University Of Liverpool
-
Khoo Saye
Department Of Pharmacology And Therapeutics University Of Liverpool
-
Back David
Department Of Pharmacology And Therapeutics University Of Liverpool
関連論文
- Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients
- A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin
- A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method
- Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds
- HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients
- New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma
- Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry